18-3879254-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004746.4(DLGAP1):c.815C>A(p.Pro272Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00002 in 1,598,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004746.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLGAP1 | NM_004746.4 | c.815C>A | p.Pro272Gln | missense_variant | 4/13 | ENST00000315677.8 | NP_004737.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLGAP1 | ENST00000315677.8 | c.815C>A | p.Pro272Gln | missense_variant | 4/13 | 5 | NM_004746.4 | ENSP00000316377.3 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000337 AC: 8AN: 237656Hom.: 0 AF XY: 0.0000156 AC XY: 2AN XY: 128136
GnomAD4 exome AF: 0.0000111 AC: 16AN: 1446282Hom.: 0 Cov.: 31 AF XY: 0.00000557 AC XY: 4AN XY: 717952
GnomAD4 genome AF: 0.000105 AC: 16AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.815C>A (p.P272Q) alteration is located in exon 4 (coding exon 1) of the DLGAP1 gene. This alteration results from a C to A substitution at nucleotide position 815, causing the proline (P) at amino acid position 272 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at